Luciferin derivative for assay of myeloperoxidase and dopamine metabolism.
Nakano
M
M
Photon Medical Research Center, Hamamatsu University School of Medicine, Shizuoka, Japan.
Koga
S
S
D001487:Basidiomycota / Q000201:enzymology; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D004578:Electron Spin Resonance Spectroscopy / Q000379:methods; D006801:Humans; D007093:Imidazoles; D007202:Indicators and Reagents; D008163:Luminescent Measurements; D014442:Monophenol Monooxygenase / Q000378:metabolism*; D009504:Neutrophils / Q000201:enzymology*; D010100:Oxygen / Q000032:analysis*; D009195:Peroxidase / Q000097:blood* / Q000302:isolation & purification; D010777:Photochemistry / Q000379:methods; D011719:Pyrazines; D026082:Singlet Oxygen; D013481:Superoxides / Q000378:metabolism
D007093:Imidazoles; D007202:Indicators and Reagents; D011719:Pyrazines; C048193:2-methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one; D013481:Superoxides; C063412:2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one; D026082:Singlet Oxygen; D009195:Peroxidase; D014442:Monophenol Monooxygenase; D010100:Oxygen; D004298:Dopamine